Dysregulated NF-κB signaling is implicated in numerous diseases, including chronic inflammatory conditions (e.g., Crohn’s disease, asthma, and psoriasis), autoimmune disorders (e.g., SLE and multiple sclerosis), and cancers (e.g., breast, lung, and colorectal cancers) (Hoesel and Schmid, 2013; Zinatizadeh et al., 2020; Lee et al., 2007). Here, NFKB1 is linked to asthma.